| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Response Pathways
Department of Biology (E.T., C.S., E.Z., J.P.), University of Crete, and Institute of Molecular Biology and Biotechnology (E.T., C.S., E.Z., A.K., J.P.), Foundation of Research and Technology, Heraklion 71110, Crete, Greece
Address all correspondence and requests for reprints to: Androniki Kretsovali, Institute of Molecular Biology and Biotechnology, Foundation of Research and Technology, Heraklion 71110, Crete, Greece. E-mail: kretsova{at}imbb.forth.gr.
We show here that steroid receptor coactivator 1 (SRC-1) is a coactivator of MHC class II genes that stimulates their interferon
(IFN
) and class II transactivator (CIITA)-mediated expression. SRC-1 interacts physically with the N-terminal activation domain of CIITA through two regions: one central [extending from amino acids (aa) 360839] that contains the nuclear receptors binding region and one C-terminal (aa 11381441) that contains the activation domain 2. Using chromatin immunoprecipitation assays we show that SRC-1 recruitment on the class II promoter is enhanced upon IFN
stimulation. Most importantly, SRC-1 relieves the inhibitory action of estrogens on the IFN
-mediated induction of class II genes in transient transfection assays. We provide evidence that inhibition by estradiol is due to multiple events such as slightly reduced recruitment of CIITA and SRC-1 and severely inhibited assembly of the preinitiation complex.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
N. Rybtsova, E. Leimgruber, Q. Seguin-Estevez, I. Dunand-Sauthier, M. Krawczyk, and W. Reith Transcription-coupled deposition of histone modifications during MHC class II gene activation Nucleic Acids Res., May 11, 2007; 35(10): 3431 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Li, J. H. Heaton, and T. D. Gelehrter Role of Steroid Receptor Coactivators in Glucocorticoid and Transforming Growth Factor {beta} Regulation of Plasminogen Activator Inhibitor Gene Expression Mol. Endocrinol., May 1, 2006; 20(5): 1025 - 1034. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gialitakis, A. Kretsovali, C. Spilianakis, L. Kravariti, J. Mages, R. Hoffmann, A. K. Hatzopoulos, and J. Papamatheakis Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A Nucleic Acids Res., February 1, 2006; 34(3): 765 - 772. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Zika, L. Fauquier, L. Vandel, and J. P.-Y. Ting Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-{gamma}-inducible MHC-II gene expression PNAS, November 8, 2005; 102(45): 16321 - 16326. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Adamski and E. N. Benveniste 17{beta}-Estradiol Activation of the c-Jun N-Terminal Kinase Pathway Leads to Down-Regulation of Class II Major Histocompatibility Complex Expression Mol. Endocrinol., January 1, 2005; 19(1): 113 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Adamski, Z. Ma, S. Nozell, and E. N. Benveniste 17{beta}-Estradiol Inhibits Class II Major Histocompatibility Complex (MHC) Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter Mol. Endocrinol., August 1, 2004; 18(8): 1963 - 1974. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |